At the news
? NEUTRALIMPACT 4/10 425 filed Jul 23, 2026 at 09:05 ET
Axalta and AkzoNobel entered into Amendment No. 2 to the Merger Agreement, modifying post-combination governance provisions in response to shareholder feedback. The amendment accelerates director re-election from a 5-year to a 3-year initial term and reduces the supermajority approval threshold from 75% to two-thirds for key board actions during that period. This is a technical governance refinement that does not alter deal economics, exchange ratio, or closing conditions, and the shareholder votes scheduled for August 5, 2026, remain on track.
- Amendment No. 2 provides for annual re-election of all MergeCo directors after the initial three-year period (previously five years).
- The approval threshold for key board actions during the initial three-year period is reduced from 75% to two-thirds of non-executive directors.
- The governance enhancements were made following 'extensive' shareholder dialogue and do not require changes to the proposed Articles of Association.
- The AkzoNobel EGM and Axalta SGM planned for August 5, 2026, are proceeding as planned with existing agenda items unaffected.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access